Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,748 total articles

Comscore Continues Building Momentum in Local Measurement Through New Agreements with More than 15 Clients

Comscore Continues Building Momentum in Local Measurement Through New Agreements with More than 15 Clients

Comscore announced new agreements with more than 15 broadcast clients, enhancing its local measurement capabilities designed for national decision-making. The company's solutions provide cross-platform audience measurement, addressing evolving viewer behaviors across linear TV, CTV, and digital platforms, and reinforcing its role as a trusted partn…

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Polaryx Therapeutics, Inc. announced that the U.S. FDA has granted Fast Track Designation for its lead drug candidate PLX-200 across all four planned indications in the SOTERIA Phase 2 basket clinical trial. These rare neurodegenerative lysosomal storage disorders include CLN2, CLN3, Krabbe, and Sandhoff diseases. Fast Track status facilitates expe…

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Enlivex Ltd. has received approval from the Danish Medicines Agency to enroll patients in a global Phase 2b clinical trial testing Allocetra, their immunotherapy for moderate-to-severe age-related primary knee osteoarthritis. This follows FDA clearance in the U.S. The randomized, placebo-controlled trial aims to evaluate Allocetra’s safety and effi…

SurgePays Advances AI Decisioning Platform Focused on Increasing Revenue Per User Across the Subprime Market

SurgePays Advances AI Decisioning Platform Focused on Increasing Revenue Per User Across the Subprime Market

SurgePays, a NASDAQ-listed wireless and fintech company, announced advancement of its AI decisioning platform integrated with ProgramBenefits.com to increase revenue per user by expanding multi-product offerings in real time. The platform uses consumer data to predict eligibility and conversion probabilities across wireless, financial services, and…

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Inc. completed a $2.15 million private placement of common stock and warrants, with potential to raise an additional $2.69 million if warrants are fully exercised. The financing will support scaling sales, inventory, and digital marketing efforts while maintaining cost discipline. Directors and officers participated in the roun…

Celularity Announces Closing of Transaction with NexGel

Celularity Announces Closing of Transaction with NexGel

Celularity Inc. completed a transaction with NexGel where NexGel acquired certain biomaterials assets and an exclusive license to develop and commercialize specific products. Celularity received $8.3 million in cash, a $5 million convertible promissory note, and potential future milestone and royalty payments up to $20 million. The deal enables Cel…

Cycurion, Inc. Provides Update on Revised Memorandum of Understanding to Acquire Kustom Entertainment’s Legacy Video Solutions Segment

Cycurion, Inc. Provides Update on Revised Memorandum of Understanding to Acquire Kustom Entertainment’s Legacy Video Solutions Segment

Cycurion, Inc., a Nasdaq-listed provider specializing in AI-driven cybersecurity and IT security solutions, announced a revised non-binding MOU with Kustom Entertainment to acquire its legacy video solutions segment. The segment is expected to add approximately $5.1 million in annual revenue and an $8 million contract backlog. The acquisition aims …

Euronet to Host Investor Day on May 20, 2026

Euronet to Host Investor Day on May 20, 2026

Euronet Worldwide, a global leader in payments processing and cross-border transactions, announced it will host an Investor Day on May 20, 2026, featuring management presentations on the company's strategic vision, growth drivers, business segments, competitive positioning, and financial outlook. The event will be webcast for investors and a replay…

Safe Harbor Introduces 401(k) Plan Built for Cannabis Employers

Safe Harbor Introduces 401(k) Plan Built for Cannabis Employers

SHF Holdings, Inc., operating as Safe Harbor, has introduced the Safe Harbor Retirement Plan, a pooled employer 401(k) designed specifically to serve state-legal cannabis businesses and their employees. This new plan addresses long-standing challenges in providing retirement benefits in the cannabis industry by offering a compliant, stable, and bro…

Eckrich Serves Up the Taste of Home and Feel-Good Moments with Campaign Celebrating Bold Flavor for Grilling Season

Eckrich Serves Up the Taste of Home and Feel-Good Moments with Campaign Celebrating Bold Flavor for Grilling Season

Smithfield Foods’ Eckrich brand has unveiled the next phase of its national campaign, “The Sausage That Takes You Home,” focusing on grilling season with a new Andouille Smoked Sausage Link product. The campaign highlights bold flavors, easy preparation, and the warmth of home-centered moments, rolling out via a comprehensive 360-degree marketing a…

Qorvo® to Distribute Quarterly Earnings on May 5, 2026

Qorvo® to Distribute Quarterly Earnings on May 5, 2026

Qorvo, a Nasdaq-listed semiconductor company, will release its fiscal 2026 fourth quarter earnings on May 5, 2026. Due to its pending merger with Skyworks, Qorvo has suspended conference calls and forward-looking guidance. The company operates in multiple high-growth sectors including automotive, consumer electronics, defense, and mobile infrastruc…

High Roller Technologies Executes Exclusive Strategic Marketing Agreement with Forever Network to Support U.S. Prediction Markets Launch

High Roller Technologies Executes Exclusive Strategic Marketing Agreement with Forever Network to Support U.S. Prediction Markets Launch

High Roller Technologies, a NYSE-listed online gaming operator, has finalized an exclusive strategic marketing agreement with Forever Network to support the launch of its regulated event-based prediction markets in the U.S. Forever Network's large digital and social media presence will drive brand awareness and user engagement for High Roller's new…

BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform

BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform

BioRestorative Therapies, a Nasdaq-listed regenerative medicine company, announced a strategic partnership with dermatologist Dr. David J. Goldberg to conduct an independent clinical study validating its secretome-derived BioCosmeceutical products. The collaboration aims to accelerate scientific validation and expand market adoption across professi…

LOBO Upgrades Claw AI Platform via “AI Director” Advisory Layer, Advancing to Enterprise-Level Strategic Decision-Making and Closed-Loop AI Agent Ecosystem

LOBO Upgrades Claw AI Platform via “AI Director” Advisory Layer, Advancing to Enterprise-Level Strategic Decision-Making and Closed-Loop AI Agent Ecosystem

LOBO TECHNOLOGIES LTD., a Nasdaq-listed electric mobility manufacturer, announced a significant upgrade to its Claw AI Agent Platform by integrating five new AI Directors to provide enterprise-level strategic advisory services. This advancement transforms the platform from operational execution tools into a comprehensive, closed-loop AI ecosystem t…

Syntec Optics ("OPTX") Advances Domestic Defense Tech with $2M Foundational Purchase Order for AI-Powered AR Cameras

Syntec Optics ("OPTX") Advances Domestic Defense Tech with $2M Foundational Purchase Order for AI-Powered AR Cameras

Syntec Optics announced a $2 million foundational order for AI-enabled augmented reality micro cameras designed for U.S. military applications, marking an expansion of its defense technology portfolio. The order initiates recurring annual revenue opportunities and leverages Syntec's vertically integrated U.S.-based manufacturing to meet stringent n…

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Cogent Biosciences announced the oral presentation of positive Phase 3 PEAK trial results combining bezuclastinib and sunitinib for advanced gastrointestinal stromal tumors (GIST) at ASCO 2026. The trial showed promising efficacy in patients previously treated with imatinib. The company has submitted a New Drug Application (NDA) under the FDA's RTO…